AcelRx Pharmaceuticals Inc expected to post a loss of 53 cents a share - Earnings Preview

Talphera

09/08/2023 03:05

* AcelRx Pharmaceuticals Inc  ACRX.OQ   ACRX.O  is expected
to show a fall in quarterly revenue when it reports  results on
August 10. 
    * The Hayward California-based  company is expected to
report  a
86.8% decrease in revenue to $75 thousand from $570 thousand a
year ago, according to the estimate from one analyst, based on
Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for AcelRx
Pharmaceuticals
Inc is for a loss of 53 cents per share. 
    * The one available analyst rating on the shares is
"hold".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​

This summary was machine generated August 9 at 02:05 GMT.  All
figures in US dollars  unless otherwise stated